Table 2 Molecular subtypes among patients (N = 30)
From: Relation between morphological features of initial breast MRI and breast cancer molecular subtypes
Molecular subtype | Number | Percent |
|---|---|---|
ER status | ||
ER Positive | 20 | 66.7 |
ER-negative | 10 | 33.3 |
PR status | ||
PR positive | 18 | 60 |
PR negative | 12 | 40 |
HER2 status | ||
HER2 positive | 12 | 40 |
HER2 negative | 18 | 60 |
Triple-negative | ||
Yes | 3 | 10 |
No | 27 | 90 |
(HR-positive, HER2-negative) | 15 | 50 |
(HR-positive, HER2 positive) | 5 | 16.7 |
HER2-enriched | 12 | 40 |
Ki-67 index status | ||
< 20 | 18 | 60 |
≥ 20 | 12 | 40 |